Found: 15
Select item for more details and to access through your institution.
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin ( LC15-0444) in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 410, doi. 10.1111/dom.12042
- By:
- Publication type:
- Article
Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 392, doi. 10.1111/dom.12064
- By:
- Publication type:
- Article
Insulin sensitivity not modulated 24 to 78 h after acute resistance exercise in type 2 diabetes patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 478, doi. 10.1111/dom.12057
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 481, doi. 10.1111/dom.12104
- By:
- Publication type:
- Article
Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 387, doi. 10.1111/dom.12018
- By:
- Publication type:
- Article
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 427, doi. 10.1111/dom.12041
- By:
- Publication type:
- Article
Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 403, doi. 10.1111/dom.12038
- By:
- Publication type:
- Article
Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 441, doi. 10.1111/dom.12049
- By:
- Publication type:
- Article
No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 417, doi. 10.1111/dom.12040
- By:
- Publication type:
- Article
The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 448, doi. 10.1111/dom.12051
- By:
- Publication type:
- Article
Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the COMPASS randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 455, doi. 10.1111/dom.12055
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. i, doi. 10.1111/j.1465-7295.2013.01683.x
- Publication type:
- Article
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 463, doi. 10.1111/dom.12090
- By:
- Publication type:
- Article
Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 474, doi. 10.1111/dom.12043
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 5, p. 432, doi. 10.1111/dom.12047
- By:
- Publication type:
- Article